Skip to main content
. 2024 Dec 16;18(12):e70041. doi: 10.1111/crj.70041

FIGURE 1.

FIGURE 1

The initial PET/CT scans and CT scans before and after treatment of Case 1. PC: the first cycle of pemetrexed (500 mg/m2) and carboplatin (AUC: 5) chemotherapy; PC + Radiotherapy:pemetrexed (500 mg/m2) and carboplatin (AUC: 5) every 3 weeks for the following two cycles and pemetrexed (500 mg/m2) for the fourth cycle, with concurrent supraclavicular and mediastinal region radiotherapy (PTV:60Gy/30F and GTVnd:66Gy/30F). Ceritinib: 450 mg orally per day. Lorlatinib: 100 mg orally per day; CT, computed tomography; MRI, nuclear magnetic resonance imaging; PD, progressive disease; PET, positron emission tomography; PR, partial remission; SD, stable disease. The red arrows point to the primary lung cancer and metastatic lymph nodes.